| Role |
Name |
Disclosure |
Details |
| Author | Richard A Santucci, MD, FACS, Chief of Urology, Detroit Receiving Hospital; Specialist-in-Chief of Urology, Detroit Medical Center; Chief of Urologic Trauma Surgery, Sinai Grace Hospital; Director, The Center for Urologic Reconstruction | Nothing to disclose | Details | | Coauthor | Hye Kim, RPh, Investigational Drug Pharmacist, Pharmacy Services, Johns Hopkins Hospital | Nothing to disclose | Details | | Coauthor | Ryan P Terlecki, MD, Staff Physician, Department of Urology, Wayne State University Health Center | Nothing to disclose | Details | | Medical Editor | Leonard Gabriel Gomella, MD, FACS, The Bernard W Godwin Professor of Prostate Cancer Chairman, Department of Urology, Associate Director of Clinical Affairs, Kimmel Cancer Center, Thomas Jefferson University | GSK Astra Zeneca | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | CME Editor | J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center | Terumo Corporation Omeros Corporation | Details | | Chief Editor | Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Hye Kim, Coauthor |
The contributor discloses no conflict of interest. |
|